Tissue heterogeneity of EGFR mutation in lung adenocarcinoma

被引:61
作者
Sakurada, Akira [1 ,2 ]
Lara-Guerra, Humberto [1 ,2 ]
Liu, Ni [1 ,2 ]
Shepherd, Frances A. [3 ]
Tsao, Ming-Sound [4 ]
机构
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada
[3] Univ Toronto, Dept Med, Toronto, ON, Canada
[4] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada
关键词
epidermal growth factor receptor; non-small cell lung cancer; mutation; heterogeneity;
D O I
10.1097/JTO.0b013e318168be93
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tissue heterogeneity of EGFR gene mutation was studied in 10 formalin-fixed paraffin-embedded (FFPE) samples from four cases that demonstrated EGFR mutations in snap-frozen samples. EGFR mutations identical to those in frozen sample were demonstrated in 8 of 10 FFPE samples by direct sequencing and in 9 of 10 by fragment length analysis, but an exon-19 deletion mutation could not be identified in one FFPE sample analyzed by both techniques, despite multiple repeated assays. This suggests that some tumors may demonstrate intratumoral heterogeneity for the occurrence of EGFR mutation.
引用
收藏
页码:527 / 529
页数:3
相关论文
共 16 条
[1]   Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: Molecular analysis of the IDEAL/INTACT gefitinib trials [J].
Bell, DW ;
Lynch, TJ ;
Haserlat, SM ;
Harris, PL ;
Okimoto, RA ;
Brannigan, BW ;
Sgroi, DC ;
Muir, B ;
Riemenschneider, MJ ;
Iacona, RB ;
Krebs, AD ;
Johnson, DH ;
Giaccone, G ;
Herbst, RS ;
Manegold, C ;
Fukuoka, M ;
Kris, MG ;
Baselga, J ;
Ochs, JS ;
Haber, DA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :8081-8092
[2]   Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib [J].
Eberhard, DA ;
Johnson, BE ;
Amler, LC ;
Goddard, AD ;
Heldens, SL ;
Herbst, RS ;
Ince, WL ;
Jänne, PA ;
Januario, T ;
Johnson, DH ;
Klein, P ;
Miller, VA ;
Ostland, MA ;
Ramies, DA ;
Sebisanovic, D ;
Stinson, JA ;
Zhang, YR ;
Seshagiri, S ;
Hillan, KJ .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5900-5909
[3]   TRIBUTE: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer [J].
Herbst, RS ;
Prager, D ;
Hermann, R ;
Fehrenbacher, L ;
Johnson, BE ;
Sandler, A ;
Kris, MG ;
Tran, HT ;
Klein, P ;
Li, X ;
Ramies, D ;
Johnson, DH ;
Miller, VA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5892-5899
[4]   Heterogeneity of p53 mutational status in the superficial spreading type of early gastric carcinoma [J].
Iwamatsu H. ;
Nishikura K. ;
Watanabe H. ;
Ajioka Y. ;
Hashidate H. ;
Kashimura H. ;
Asakura H. .
Gastric Cancer, 2001, 4 (1) :20-26
[5]   A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening [J].
Jänne, PA ;
Borras, AM ;
Kuang, YN ;
Rogers, AM ;
Joshi, VA ;
Liyanage, H ;
Lindeman, N ;
Lee, JC ;
Halmos, B ;
Maher, EA ;
Distel, RJ ;
Meyerson, M ;
Johnson, BE .
CLINICAL CANCER RESEARCH, 2006, 12 (03) :751-758
[6]   Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas [J].
Kitago, M ;
Ueda, M ;
Aiura, K ;
Suzuki, K ;
Hoshimoto, S ;
Takahashi, S ;
Mukai, M ;
Kitajima, M .
INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (02) :177-182
[7]   Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer [J].
Klein, CA ;
Blankenstein, TJF ;
Schmidt-Kittler, O ;
Petronio, M ;
Polzer, B ;
Stoecklein, NH ;
Riethmüller, G .
LANCET, 2002, 360 (9334) :683-689
[8]   Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].
Lynch, TJ ;
Bell, DW ;
Sordella, R ;
Gurubhagavatula, S ;
Okimoto, RA ;
Brannigan, BW ;
Harris, PL ;
Haserlat, SM ;
Supko, JG ;
Haluska, FG ;
Louis, DN ;
Christiani, DC ;
Settleman, J ;
Haber, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139
[9]   Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp [J].
Nagai, Y ;
Miyazawa, H ;
Huqun ;
Tanaka, T ;
Udagawa, K ;
Kato, M ;
Fukuyama, S ;
Yokote, A ;
Kobayashi, K ;
Kanazawa, N ;
Hagiwara, K .
CANCER RESEARCH, 2005, 65 (16) :7276-7282
[10]   Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas [J].
Pan, QL ;
Pao, W ;
Ladanyi, M .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2005, 7 (03) :396-403